Medical Catheter Hydrophilic Nano Coating: From Surface Tribology to ISO 10993 Biocompatibility

2026-07-08 · Classificazione: Technical Knowledge

🌐 Questo articolo è stato tradotto automaticamente dall'intelligenza artificiale; il testo originale è in cinese. Per qualsiasi domanda, si prega di fare riferimento al testo originale in cinese. · 查看中文原文
▲ Medical Catheter Nano Hydrophilic Lubrication: UV-Cured Hydrophilic Polymer(20nm-several um) Absorbs Water Forms Lubrication Film->COF Bare 0.20-><0.05(Wet)->AgSC-PPMA Hydrogel COF=0.014(Bare 1/64)->Antibacterial>99.99%+60-Day->ISO 10993 Full Biocompatibility->Global Catheter $48B 2025

Medical catheter hydrophilic nano coatings use UV-cured hydrophilic polymers or nano-hydrogel coatings (AgSC-PPMA, CAPPN) constructing nanoscale (20nm-several um) hydrophilic lubricious layers. AgSC-PPMA hydrogel coating: COF 0.014 (1/64 of bare catheter), antibacterial>99.99%, 60-day longevity. CAPPN hydrogel: COF 0.14 (bare 0.21, -33%), cell viability>93.2%, hemolysis<0.82%. SuSoS AziGrip4 LUB: COF<0.05 (wet). Teleflex Medical OEM: ISO 10993-5/10/7/4/18+USP 788. CytaCoat LubriShield: covalent-bonded hydrophilic, non-biocidal anti-biofilm. Toray self-assembly nano hydrophilic (~20nm): COF -90%, wettability +20x. Two 2026 ScienceDirect high-impact papers report CQDs+hydrogel and AgNP microcapsule hydrogel catheter coating breakthroughs. Global catheter market ~$48B (2025), CAGR 8.5%. Hydrophilic coated catheters: ~30% (2020) to ~50%+ (2025). ISO 10993 series, USP Class VI, ISO 13485, FDA 510(k) compliant.

Etichetta: #medical device